Scholarship table
NVTA!
i don't know what the definitions of upper, upper mid and middle class are, but i sure do not view myself as "wealthy" i have been able to provide well for my family and able to enjoy some nice things. if not for the economic blow-out of 2008-09, it never would have crossed my mind to buy a 2nd home. i was just in the right place at the right time. my parents had been going down to lake havasu city for 25 years. i was somewhat familiar with havasu and really liked it! after 7 years, it rebounded by 40%. couple that with the 20% down, 7 years of pay down on the mortgage and we eagerly sold and reinvested in a little bigger/better in surprise, Az. probably the best all around choices i've ever made. it sure as hell saved my sanity from march 17-april 27
You don't usually see the acquiring company go up like that
Very true. The combined expertise of NVTA and ArcherDX will be a paradigm shifter in the cancer arena.Another early stage candidate doing some great work is WRTC - founded by an acquaintance of mine. Share price has run up lately, yet the product has great potential for worldwide adoption.Anyone looking to take a flier on an early-stage biotech that has good potential should look at ONTX currently trading at $0.58/share.
See ... THIS is the kind of executive-level stuff I find reprehensible ...https://www.foxbusiness.com/retail/macys-bonuses-executives-job-cutsMacy's doled out $9 million in equity bonuses to its top executives just two weeks after the retailer said it would cut thousands of jobs in its corporate office.CEO Jeff Gennette received restricted stock worth about $3.6 million on July 9, according to a regulatory filing. The other five, including legal chief Elisa Garcia, Chief Operating Officer John Harper and Chief Transformation Officer Danielle Kirgan, received sums ranging from $900,000 to $3 million, according to the filings.I don't like painting anybody with a broad brush, so I am NOT saying "CEOs are bad," or anything of the like. I am saying actions like this one -- which are all too common -- are unethical, immoral and, well, pretty close to evil.
ONTX mentioned above on the move today. WRTC is still a good play even though up 33% from time of above post.
Think Ellenson Family Reunion gives some good advice above. This dip is a great thing for you being 30 years out. If you are a buy and hold guy, ideas I'd present would be: AMRN, ETSY, ULTA, RVLV, SQ, BA, SHOP, CTAS.Higher volatility biotechs I like (a sector invest 50% of my portfolio): AXSM, FLGT, GNPX, NVTA, SAVA, AQST, IGMS.Bloom Energy (BE) is also an interesting company with a bright future IMO.Invest at your own risk above. Just sharing some ideas.
Hope some of you got in on these. BE, ETSY, SQ, RVLV, FLGT, AQST, NVTA all 4 baggers.I just hit a nice home run on some APPS calls that I bought 4 weeks ago. Entering overbought territory now, but they have a very bright future. Also got in on CLSK last Thursday and that has run up nicely.I'm hoping to buy in on OTRK if it will drop back into the mid $40s.
Could one of you guys explain WTF is going on in the markets?I get it .. unemployment isn't the only driver for "the market" or "the economy" .. but revenue sure as hell does.Yes, there are industries whose revenues are normal or higher in COVID times. E-commerce. Tech providers. Video conferencing. Grocery. But tons of industries will have massively reduced revenue, now and into 2021. There is massive uncertainty in what is going to happen. If there's massive risk .. and revenues will be way down for a huge chunk of the global economy -- for years -- how the hell is the market near it's highest ever? I'll hang up and listen.
If you can print endless money to buy various financial vehicles, you can back stop the market. Basically the Fed has been buying Trillions in bonds, ETFs, and the like over the last few months. This in turn gives funds the confidence to know they wont let the markets fall. So they buy aggressively and factor that support into their long term projections.This is a few big names, like AMZN or other tech leaders, who had great revenues during COVID times (and are a large part of indicies so when they go up, it pushes indicies up) and the Fed pushing money and liquidity into the market and being the tide that lifts all boats.
And what happens when the fed stops putting money in? Or what are the long-term ramifications of this money printing?
Because the big funds, pension trusts like the Pennsylvania Public School Employee's Retirement System hold blue chips and don't trade much.I suggest most of you guys get a real job and save your money.Most of you won't because you believe in the propaganda of Wall Street. Besides gambling is fun.
It is what it is. Diversify. Some cash is important for emergencies, but invest in things that are more inflation-proof. There's lots of good options.
We will see air pockets of downside. Unfortunately none of this is sustainable. The long term ramifications is inflation, and hyper inflation if it gets really bad. It’s trading potential long term chaos for short term stability and “protection”Does it ever get exhausting being a pretentious know it all jackass?Nobody in here is day trading. Most everyone has a sensible investing strategy and realistic goals and expectations.Have fun with your sub 1% savings rate while other people bought into that “propaganda” and got 10-20x that in gains annually, while in conservative ETFs and index funds, Not everyone has a absurd bloated pension fund to provide for them in their old age while they stash cash under their mattress
you got your wish
Still believe AMRN is a a great investment at its current $7.62 share price. Revenues doubled 3 years in a row and Q1 2020 up 108% over Q1 2019. Market cap of only 2.94B. $645M Cash on hand. Suspect this is being held down by big pharma as their one drug, Vascepa, will disrupt the whole cardiovascular drug market, and how care is delivered.Some big catalysts ahead in near term for AMRN, with readouts of their EVAPORATE study - which essential shows clearing of arteries - which can eliminate need for stenting. European approval and partners should be announced in Q3.I now have 50% of my portfolio invested into AMRN dollar cost averaged down to $8.25.